Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. UPLOAD Other SEC-generated Letter
  2. S-1 Offering Registration Statement
  3. 4 Grant or award Director acquired 43,093 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 14,817,329 shares (grant or award)
  5. 4 Grant or award 10% owner acquired 13,971,864 shares (grant or award)
  6. 4 Grant or award Director acquired 1,644,793 shares (grant or award)
  7. 4 Grant or award Director acquired 41,686 shares (grant or award)
  8. 4 Grant or award Director acquired 13,168 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 432,750 shares (grant or award)
  11. 4 Grant or award General Counsel & Secretary acquired 6,320 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 16 of 24 · 479 filings